Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2477057 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| Triethylene Glycol SCHEMBL9447828 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL315062 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL3861837 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL9447825 | 0.97 | TSHR (0.67) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL9111 | 0.97 | — | — | |
| Dimethylamine SCHEMBL28297119 | 0.89 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| Triethylene Glycol SCHEMBL2009780 | 0.87 | MEN1 (0.52) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL28179683 | 0.87 | MEN1 (0.79) | MEN1KMT2ATSHRMAPK1THRB | |
| 2-Chloroethanol SCHEMBL11553025 | 0.87 | TSHR (0.50) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329748-A1 | INDIRUBIN COMPOUNDS AND METHODS THEREOF | Jawaharlal Nehru Centre For Advanced Scientific Research (IN) | 2024-03-06 | — | — | EP | disclosed |
| WO-2022229986-A1 | INDIRUBIN COMPOUNDS AND METHODS THEREOF | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2022-11-03 | — | — | WO | disclosed |
| EP-2372017-B1 | SOFTENER COMPOSITION | KAO CORP (JP) | 2017-09-13 | — | — | EP | disclosed |
| US-8497235-B2 | Softener composition comprising ethoxylated esterquats | KAO CORPORATION (JP) | 2013-07-30 | — | — | US | disclosed |
| US-20110263476-A1 | SOFTENER COMPOSITION | KAO CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-2372017-A1 | SOFTENER COMPOSITION | Kao Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-6899823-B2 | Liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20020102366-A1 | Compounds, polymeric compounds and method of utilizing the same | CANON KABUSHIKI KAISHA (JP) | 2002-08-01 | — | — | US | disclosed |
| US-4145342-A | NITRO-DIPHENYLAMINO-AZO-PHENYL DYESTUFFS CONTAINING A POLYALKYENEOXY GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263476-A1 | SOFTENER COMPOSITION | H1-0, H1-10, H1-2 | MEN1 2902/4885KMT2A 159/4885TSHR 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.